Skip to main content
Open Access Publications from the University of California

Patient's Health: The Number One Priority in the Treatment of Cancer


Bringing about the discussion of the importance of proposing and researching cancer treatments that not only focus on treating cancer but also equally focus on the patient’s health during and after treatment is a topic within cancer research that is minimally discussed. This literature review uses childhood acute lymphoblastic leukemia(ALL), which is a type of cancer that produces immature lymphocytes and doxorubicin, a treatment option for those with ALL that is known to cause cardiotoxicity years after treatment to encourage holistic approaches and longitudinal research on cancer treatments that focus on the patient’s well-being during and after treatment is received.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View